Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter
ConditionAdenocarcinoma of Lung
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTang-Du Hospital
About this trial
The core purpose of this study is to investigate whether the extracellular volume (ECV) fraction measured in delay phase by dual energy computed tomography (DECT) can distinguish precancerous lesions from early-stage lung adenocarcinomas, which could assist clinical decision making for surgery operation indication and strategy.
Eligibility criteria
Qualifiers
patients older than 18 years old with pulmonary nodules (diameter≤3 cm).
pathologically confirmed as lung adenocarcinoma.
without history of other malignancies.
accurate hematocrit within 1 week before contrast enhanced dual energy CT examination.
Disqualifiers
with a history of allergy to iodine contrast agents and other reasons who are unable to complete the examination.
without histopathology of invasion stage, such as AAH, AIS, MIA and IAC.
history of chemotherapy, radiotherapy, or other anti-tumor therapy before contrast enhanced dual energy CT.
poor image quality.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,000 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov